MedPath

The comparison between co-administration of surfactant and fentanyl with administration of surfactant in decreased order of repeated doses of surfactant in neonatal with respiratory distress syndrome

Phase 3
Conditions
Respiratory distress syndrome.
Respiratory distress syndrome of newborn
Registration Number
IRCT20180729040633N1
Lead Sponsor
Bojnourd University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
30
Inclusion Criteria

All of the preterm neonates with 30 - 36 weeks of gestational age
800 - 2500 gram neonates
Neonates with respiratory distress syndrome at Bojnourd Bentolhoda Hospital

Exclusion Criteria

Neonates of addicted mothers
Neonates with less than 800 and more than 2500 gram weight
Patients with less than 30 and more than 36 weeks of gestational age
Parental dissatisfaction
Neonates of mothers with severe hypertension and chorioamnionitis
Very ill patients

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The dose of surfactant in infants with respiratory distress syndrome. Timepoint: At the end of the study (the amount of surfactant administered until recovery). Method of measurement: Milligrams.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath